Emergent BioSolutions (EBS) Debt Ratio (2010 - 2026)

Emergent BioSolutions' Debt Ratio history runs 17 years deep, the most recent figure standing at 0.43 for Q1 2026.

• In Q1 2026, Debt Ratio fell 6.94% year-over-year to 0.43; the TTM figure through Mar 2026 stood at 0.43 (down 6.94% YoY), while the FY2025 annual figure was 0.43, down 9.15% from the prior year.
• Debt Ratio was 0.43 for Q1 2026 at Emergent BioSolutions, roughly flat from 0.43 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.48 in Q4 2024 to a low of 0.14 in Q4 2022.
• Historically, Debt Ratio has averaged 0.33 across 5 years, with a median of 0.3 in 2024.
• The sharpest annual moves came in 2022 and 2024: Debt Ratio sank 48.24% in 2022, then jumped 95.01% in 2024.
• A 5-year view of Debt Ratio shows it stood at 0.14 in 2022, then soared by 72.89% to 0.24 in 2023, then surged by 95.01% to 0.48 in 2024, then slipped by 9.15% to 0.43 in 2025, then gained by 0.13% to 0.43 in 2026.
• The last three Debt Ratio figures came in at 0.43 (Q1 2026), 0.43 (Q4 2025), and 0.45 (Q3 2025), per Business Quant data.